Inogen Inc.

6.65
-0.15 (-2.21%)
At close: Mar 31, 2025, 12:25 PM

Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.

Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories.

The company also rents its products directly to patients.

Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen Inc.
Inogen Inc. logo
Country United States
IPO Date Feb 14, 2014
Industry Medical - Devices
Sector Healthcare
Employees 766
CEO Kevin R. M. Smith

Contact Details

Address:
301 Coromar Drive
Goleta, California
United States
Website https://www.inogen.com

Stock Details

Ticker Symbol INGN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001294133
CUSIP Number 45780L104
ISIN Number US45780L1044
Employer ID 00-0000000
SIC Code 3842

Key Executives

Name Position
Kevin R. M. Smith President, Chief Executive Officer & Director
Michael J. Bourque C.P.A. Executive Vice President, Chief Financial Officer & Corporate Treasurer
Adrien Mithalal Senior Vice President of Research & Development
Dr. Krishna Jhaveri Chief Medical Officer
Grgoire Ramade Executive Vice President & Chief Commercial Officer
Jennifer Yi Boyer Executive Vice President & Chief Human Resources Officer
Kevin P. Smith General Counsel, Secretary & Executive Vice President of Business Development
Paul Andreassi Senior Vice President of Quality & Regulatory Affairs
Philip Corrin Senior Vice President of Operations & Supply Chain

Latest SEC Filings

Date Type Title
Mar 27, 2025 ARS Filing
Mar 27, 2025 DEFA14A Filing
Mar 27, 2025 DEF 14A Filing
Mar 04, 2025 4 Filing
Mar 04, 2025 4 Filing
Mar 04, 2025 4 Filing
Mar 04, 2025 4 Filing
Feb 28, 2025 S-8 Filing
Feb 28, 2025 10-K Annual Report
Feb 25, 2025 8-K Current Report